ConductScience.org, home

Paper35787271

Diabetic retinopathy with extensively large area of capillary non-perfusion: characteristics and treatment outcomes.

Huang Z and 11 others. BMC Ophthalmol, 2022. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. Diabetic retinopathy with extensively large area of capillary non-perfusion: characteristics and treatment outcomes. Papers, record 35787271. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35787271

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Diabetic retinopathy with extensively large area of capillary non-perfusion: characteristics and treatment outcomes.
PubMed
Journal
BMC Ophthalmol
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
1.74
iCite
Revised in PubMed
2022-07-16
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Huang ZZijing
2Qiu KKunliang
3Yi JJingsheng
4Lin HHongjie
5Zheng DDezhi
6Huang DDingguo
7Zhang GGuihua
8Chen HHaoyu
9Zheng JJianlong
10Wang YYifan
11Fang DDanqi
12Chen WWeiqihttps://orcid.org/0000-0003-2852-8192

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetes MellitusMajor topic
Diabetic RetinopathyMajor topic
Humans
Laser Coagulation
Retrospective Studies
Treatment Outcome
Visual Acuity

Source PubMed

Download CSV of topics

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129492053Fundus fluorescence Angiography in diagnosing diabetic retinopathy.Pak J Med Sci2017https://conductscience.org/library/papers/29492053PubMed
224747681A comprehensive texture segmentation framework for segmentation of capillary non-perfusion regions in fundus fluorescein angiograms.PLoS One2014https://conductscience.org/library/papers/24747681PubMed
328365411Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials.Lancet Diabetes Endocrinol2017https://conductscience.org/library/papers/28365411PubMed
430769149Retinal capillary perfusion: Spatial and temporal heterogeneity.Prog Retin Eye Res2019https://conductscience.org/library/papers/30769149PubMed
528490862Ultra-wide-field fluorescein angiography in diabetic retinopathy: a narrative review.Clin Ophthalmol2017https://conductscience.org/library/papers/28490862PubMed
69046048Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease.Histol Histopathol1997https://conductscience.org/library/papers/9046048PubMed
731383482Quantitative Ultra-Widefield Angiography and Diabetic Retinopathy Severity: An Assessment of Panretinal Leakage Index, Ischemic Index and Microaneurysm Count.Ophthalmology2019https://conductscience.org/library/papers/31383482PubMed
822080911Ultra-wide-field angiography improves the detection and classification of diabetic retinopathy.Retina2012https://conductscience.org/library/papers/22080911PubMed
923649946Soluble mediators of diabetic macular edema: the diagnostic role of aqueous VEGF and cytokine levels in diabetic macular edema.Curr Diab Rep2013https://conductscience.org/library/papers/23649946PubMed
1026929922Detection of retinal capillary nonperfusion in fundus fluorescein angiogram of diabetic retinopathy.Bioimpacts2015https://conductscience.org/library/papers/26929922PubMed
116367724The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years.Arch Ophthalmol1984https://conductscience.org/library/papers/6367724PubMed
1230068515Peripheral capillary non-perfusion in treatment-naïve proliferative diabetic retinopathy associates with postoperative disease activity 6 months after panretinal photocoagulation.Br J Ophthalmol2019https://conductscience.org/library/papers/30068515PubMed
1319262436Panretinal photocoagulation combined with intravitreal bevacizumab in high-risk proliferative diabetic retinopathy.Retina2009https://conductscience.org/library/papers/19262436PubMed
1427779095Associations between diabetic retinopathy and systemic risk factors.Hong Kong Med J2016https://conductscience.org/library/papers/27779095PubMed
1527128219Angiogenesis and Inflammation Crosstalk in Diabetic Retinopathy.J Cell Biochem2016https://conductscience.org/library/papers/27128219PubMed
1621726427Panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab for high-risk proliferative diabetic retinopathy.Acta Ophthalmol2011https://conductscience.org/library/papers/21726427PubMed
1728580199The Role of Systemic Risk Factors in Diabetic Retinopathy.Curr Ophthalmol Rep2016https://conductscience.org/library/papers/28580199PubMed
1819651921Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.Diabetes Care2009https://conductscience.org/library/papers/19651921PubMed
1914514599Signs of nephropathy may occur early in young adults with diabetes despite modern diabetes management: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS).Diabetes Care2003https://conductscience.org/library/papers/14514599PubMed
2027417506Macular atrophy in patients with long-term anti-VEGF treatment for neovascular age-related macular degeneration.Acta Ophthalmol2016https://conductscience.org/library/papers/27417506PubMed

See all 31 referencesDownload CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
42550914The role of ceramides in the pathophysiology of diabetic retinopathy: Mechanisms and Implications for therapeutic strategies.Diab Vasc Dis Res2026https://conductscience.org/library/papers/42550914PubMed
42012258Macular, Peripapillary, and Midperipheral Nonperfusion in Diabetic Subjects: A Wide-Field OCTA Quantification.Transl Vis Sci Technol2026https://conductscience.org/library/papers/42012258PubMed
41915053Short-term natural history of non-perfusion areas in treatment-naive diabetic retinopathy patients using swept-source OCT angiography.Graefes Arch Clin Exp Ophthalmol2026https://conductscience.org/library/papers/41915053PubMed
41772745Assessment of glycemic control among patients undergoing surgical treatment for advanced diabetic retinopathy in Saudi Arabia.Int J Retina Vitreous2026https://conductscience.org/library/papers/41772745PubMed
41587134MAGIC: Study Design and Rationale for the Phase 2 Clinical Trial of Faricimab for Non-Proliferative Diabetic Retinopathy.Ophthalmologica2026https://conductscience.org/library/papers/41587134PubMed
41574824Erythrocyte deformability correlates with microvascular ischemia and disease severity in diabetic retinopathy.J Diabetes Investig2026https://conductscience.org/library/papers/41574824PubMed
39797135Predictors of Peripheral Retinal Non-Perfusion in Clinically Significant Diabetic Macular Edema.J Clin Med2024https://conductscience.org/library/papers/39797135PubMed
38592149The Treatment of Diabetic Retinal Edema with Intravitreal Steroids: How and When.J Clin Med2024https://conductscience.org/library/papers/38592149PubMed
38438795Retinal non-perfusion: recognizing and defining what is important.Eye (Lond)2024https://conductscience.org/library/papers/38438795PubMed
37035306Peripheral and central capillary non-perfusion in diabetic retinopathy: An updated overview.Front Med (Lausanne)2023https://conductscience.org/library/papers/37035306PubMed
36983406Retinal Ischaemia in Diabetic Retinopathy: Understanding and Overcoming a Therapeutic Challenge.J Clin Med2023https://conductscience.org/library/papers/36983406PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213NCBI Gene
VEGFA7422PubTator's text mininghttps://conductscience.org/library/genes/7422NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35787271

GET https://conductscience.org/api/papers/v1/35787271/references?page=2